Let's see how simply adjusting the way you view cutting losses can help you become a better trader.
Let's see why the old 'buy low, sell high' advice doesn't always work.
The "crowd" remains heavily bullish even as valuations for the S&P 500 become quite extended.
The action broadened on Thursday, but a small group of big stocks still dominated.
Insider buying by the new CEO of this buyer of biopharmaceutical royalties, puts this name on my radar.
Significant blocks of stock were bought in both companies, which each have seen their shares decline by more than half so far this year.
The big purchases in these two concerns have come in just the last two weeks.
A hardware giant and a biotech focused on ocular diseases have seen insider buying of late.
Some interesting insider purchases and possible new trade ideas as we begin a difficult week.
A provider of technology for managing smart homes and a financial services concern are finding interests from directors and officers.